A look at the following clinical trial: A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus.
A look at the following clinical trial: A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma.
A look at the following clinical trial: A Phase 1B Dose-escalation Study of TRC105 in Combination With Axitinib in Patients With Advanced Renal Cell Carcinoma.
A look at the following clinical trial: Carfilzomib in Refractory Renal Cell Carcinoma (RCC).
A look at the following clinical trial: Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer.
A look at the following clinical trial: Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus (NEORAD).
A look at the following clinical trial: Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC).
A look at the following clinical trial: Neoadjuvant Pazopanib in Renal Cell Carcinoma.
A look at the following clinical trial: Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma (Everolimage).
A look at the following clinical trial: Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma.
Please login or register first to view this content.
